Krystal Biotech, Inc. (KRYS)
272.74
+5.10
(+1.91%)
USD |
NASDAQ |
Feb 06, 16:00
272.02
-0.72
(-0.26%)
After-Hours: 20:00
Krystal Biotech SG&A Expense (TTM) : 136.75M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Amicus Therapeutics, Inc. | 353.07M |
| DexCom, Inc. | 1.297B |
| Alkermes Plc | 661.32M |
| Regeneron Pharmaceuticals, Inc. | 2.70B |
| Alnylam Pharmaceuticals, Inc. | 1.181B |